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Ribonucleoprotein assembly: Clues from spinal muscular atrophy
Iain W. Mattaj
Mutation or deletion of one of the two genes encoding
a protein known as SMN has recently been shown to
cause spinal muscular atrophy. The SMN protein has
been found to be part of a multi-component complex
that appears to function in the assembly of cellular
ribonucleoprotein particles.
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Spinal muscular atrophy is one of the most common
human autosomal recessive disorders. In spinal muscular
atrophy patients, motor neurons from the anterior horn of
the spinal cord degenerate, resulting in the loss of muscle
innervation and subsequent muscular atrophy. Three
forms of spinal muscular atrophy, types I, II and III, have
been distinguished on the basis of the severity; only type
III patients have a chance of survival beyond infancy
(reviewed in [1]). Until recently, the genetics of spinal
muscular atrophy had been too complex to understand,
but the identification of the disease gene, called survival
motor neuron or SMN [2], has now allowed progress to be
made in this area. This progress establishes a connection
with a surprising aspect of cell biology — the assembly of
ribonucleoprotein (RNP) particles. 
The human SMN locus is part of a large inverted
duplication on chromosome 5, with one copy of the gene
being present in each repeat. The two gene copies
encode identical amino acid sequences, and both are
expressed ([3] and references therein). They are there-
fore distinguished by their location as the SMNC (cen-
tromeric) and SMNT (telomeric) genes. The duplication
event appears to be relatively recent; mice, for example,
have a single SMN gene. Moreover, the duplicated
human locus is highly polymorphic [4], and this genetic
instability probably explains the high frequency of spinal
muscular atrophy.
Patients lacking both SMNC and SMNT have not been
reported, suggesting that deletion of both genes causes
embryonic death. Individuals lacking just SMNC, however,
are normal; the vast majority of spinal muscular atrophy
patients have abnormalities associated with the SMNT
locus. The most severely affected (spinal muscular
atrophy type I) patients either lack SMNT, as a result of a
chromosomal deletion, or have specific mutations in this
copy of the gene [1,4]. Patients with spinal muscular
atrophy types II or III have other, presumably less delete-
rious, mutations in SMNT, including cases where all or part
of the SMNT gene is replaced by a second copy of the
SMNC locus as a result of gene conversion, an event that
can be accompanied by the generation of additional SMNC
copies [1,4]. Thus, the presence of two or even more
copies of SMNC does not compensate for the loss of SMNT.
The mutations that cause spinal muscular atrophy appear
to have similar effects on SMN protein production.
Although some tissues or cell lines derived from spinal
muscular atrophy patients still produce SMN protein at
near-normal levels, other tissues, like liver or, notably,
spinal motor neurons, either lack or have greatly reduced
levels of SMN protein [3,5]. The simplest explanation for
these observations is that spinal muscular atrophy is
caused by insufficient production of SMN protein in
motor neurons, which appear to express higher levels of
SMN than other cell types [3,5]. This can be the result of
mutation of either the SMNT protein or of an element
required for the expression — acting at the level of tran-
scription, processing, nuclear export, translation or stabil-
ity — of SMNT mRNA. According to this view, the
specificity of the effects on motor neurons would reflect a
quantitatively greater requirement for SMN in these cells
to carry out a general ‘housekeeping’ function. But as
expression in other tissues, such as liver, is also greatly
reduced in spinal muscular atrophy patients [5], it is also
possible that SMN has a specific function in motor
neurons, and that loss of this function underlies spinal
muscular atrophy.
SMN’s partners
What might the function of SMN be? The first clue came
from a serendipitous observation made in a ‘two-hybrid’
screen for proteins that will interact with SMN in yeast
cells. SMN was found to interact specifically with an
RNA-binding protein, suggesting that its function might
be related to RNA metabolism [6]. This possibility
received some support from the intracellular location of
SMN. Although SMN was found throughout the cell, it
was most concentrated in a small number (three to eight)
of structures found scattered in the nucleus [6]. These
structures were frequently located adjacent to so-called
‘coiled bodies’, and were thus christened ‘gemini of coiled
bodies’ or gems.
The function of coiled bodies is not known, but their rela-
tionship to RNP particles is well established. Coiled bodies
contain high concentrations of the U small nuclear
(sn)RNPs, which are involved in nuclear pre-mRNA
processing, as well as components of the small nucleolar
(sno)RNPs, which play a role in pre-ribosomal RNA metab-
olism [7]. The proximity of gems and coiled bodies implied
that gems might also have some association with this group
of RNPs. This implication has been confirmed in two
recent papers [8,9] and evidence that the SMN protein may
function in RNP assembly has been presented.
These studies began with another two-hybrid screen, this
time using the SMN protein itself as a bait. A protein
called SIP1 (‘SMN interacting protein 1’) was selected and
shown to interact directly with SMN in vitro [8].
Immunolocalisation of SIP1 revealed a distribution identi-
cal to that of SMN, with a low concentration throughout
the cell and intense staining of gems. Immunoprecipitation
of human cell extracts with either SMN or SIP1 antibodies
co-precipitated the other protein, demonstrating their asso-
ciation in vivo. The SMN–SIP1 complexes were found to
be very large, roughly 300 kDa. They contain numerous
stably bound components apart from SMN and SIP1,
several of which were shown to be U snRNP proteins [8].
U snRNPs function in the maturation of mRNA precur-
sors. They consist of one or two RNA molecules and a
number of proteins. The proteins can be divided into two
general classes: specific proteins that are uniquely associ-
ated with one of the U snRNAs and common proteins that
associate with all U snRNAs [10,11]. The common pro-
teins all contain a related domain, the Sm domain, so
named because it is recognised by autoimmune sera of the
Sm serotype (reviewed in [12]). All but two of these Sm
proteins bound recombinant SMN protein when trans-
lated in vitro and incubated with SMN [8]. This implies an
interaction between SMN and the Sm domain, but as
these experiments involved the use of reticulocyte lysates,
they do not prove direct interaction. SIP1 did not interact
with the Sm proteins in similar assays. Evidence that
these in vitro interactions reflect in vivo function came
from the presence of U snRNAs or U snRNP proteins in
SMN or SIP1 immunoprecipitates of cytoplasmic fractions
of Xenopus laevis oocytes or whole cell extracts of HeLa
cells, respectively [8,9].
SMN and U snRNP assembly
In vertebrates, U snRNP assembly involves transcription
of the pre-U snRNA and its export to the cytoplasm.
There, the RNA joins with the Sm proteins, allowing
further events involved in the maturation of U snRNPs to
occur, including the formation of the trimethyl cap struc-
ture on the U snRNAs [10,11]. Xenopus oocytes have been
favourite cells for the study of U snRNP assembly, as
massive quantities of the Sm proteins are stored in the
oocyte cytoplasm for use during early embryogenesis [10].
Like the Sm proteins, SMN and SIP1 have a different
location in oocytes and somatic cells, being almost entirely
cytoplasmic in oocytes. Association of SMN and SIP1 with
newly assembled U snRNPs could be demonstrated in
the cytoplasm, but not the nucleus, of oocytes [9].
This suggested that SMN and SIP1 are involved in U
snRNP assembly, a hypothesis that was tested by intro-
ducing U snRNAs into the oocyte cytoplasm by microin-
jection. The assembly of the U snRNAs into U snRNPs
was monitored in the presence of antibodies specific for
SMN or SIP1. Remarkably, both antibodies affected U
snRNP assembly. The most dramatic effect was caused by
the antibodies against SIP1, which efficiently blocked the
assembly of U1, U2, U4 and U5 snRNPs. Conversely, the
antibodies against SMN stimulated U snRNP formation
[9]. These effects were not specific for a particular U
snRNA and were interpreted as evidence that SMN and
SIP1 have a role in U snRNP assembly [9], perhaps
equivalent to that played by chaperonins in multi-protein
complex assembly. If this were indeed the case, SMN and
SIP1 will be the first identified cellular RNP assembly
factors that are not part of the RNP particle that they help
assemble. If for no other reason, they are therefore
extremely interesting proteins.
There are obvious questions raised by these findings. What
has U snRNP assembly, a cytoplasmic event, got to do
with gems, the sites of highest SMN and SIP1 concentra-
tion? The answer might be “more than we would imagine”.
If mutant forms of either SMN or SIP1 are made in mam-
malian cells, large aggregates containing SMN and SIP1
form in both nucleus and cytoplasm. Among many other
coiled-body components, the nuclear aggregates contain
mature, trimethylated U snRNAs (G. Dreyfuss, personal
communication). This supports the initial contention [6]
that gems and coiled bodies may be functionally related,
and that U snRNPs, although not detectably associated
with SMN or SIP1 in the nucleus at steady state, might
transiently interact with them (an interaction that might be
stabilized by mutation of SMN or SIP1, causing aggrega-
tion). In turn, this would suggest that SMN and SIP1 could
be involved in recycling U snRNPs in the nucleus, a func-
tion related to U snRNP assembly in the cytoplasm.
What about the specificity of the effects in spinal
muscular atrophy of SMN underexpression in motor
neurons compared with other tissues, such as liver, that
seem to show similarly reduced expression [5]. This may
reflect a greater need for SMN in motor neurons, where
both SMN and SIP1 are particularly highly expressed
[3,5]. However, there is a second possibility worth consid-
ering. Two of the Sm proteins that are abundant in HeLa
cell U snRNPs, B and B′, are barely expressed in neurons,
where they are replaced by a neuron-specific Sm protein.
Perhaps the neuron-specific Sm protein interacts differ-
ently with SMN; if so, the choice of name for this protein
was prophetic, as it is called SmN [13].
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Analysis of the as yet uncharacterised protein components
of the SMN–SIP1 complex may provide new clues to its
function. It will be of interest to examine the effects of
SMN and SIP1 on the assembly of other RNPs, including
nucleolar RNPs that assemble in the nucleus and splicing
complexes that assemble on mRNA precursors. Additional
studies of the effects of mutant forms of the proteins on
mammalian cells may provide further insight into the rela-
tionship between gems, coiled bodies and nuclear compo-
nents involved in RNA metabolism. Aside from this, the
existence of an obvious SMN homologue in Schizosaccha-
romyces pombe [14] and of a very distant, but provocative,
relationship between SIP1 and the Saccharomyces cerevisiae
protein Brr1, which has been implicated in U snRNP
assembly in that organism [15], suggests that a conven-
tional genetic approach to SMN and SIP1 function will be
both possible and rewarding. 
Finally, the existence of an in vitro U snRNP assembly
system [16] will provide the possibility for a direct
biochemical test of the role of SMN and SIP1 in this
process. Although U snRNP assembly in vitro occurs in
the apparent absence of SMN and SIP1 [16], it is not
efficient. Perhaps immunopurified SMN–SIP1 complexes
will support assembly in a manner that more closely
resembles the in vivo situation. Not for the first time, very
specific pathological defects may turn out to be derived
from defects in a very general biological process.
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